Novavax, Inc.
NVAX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $1,407,601 | $1,020,720 | $1,032,324 | $1,288,338 |
| - Cash | $268,023 | $264,493 | $263,338 | $530,230 |
| + Debt | $251,140 | $228,490 | $228,659 | $230,419 |
| Enterprise Value | $1,390,718 | $984,717 | $997,645 | $988,527 |
| Revenue | $70,445 | $239,240 | $666,655 | $88,311 |
| % Growth | -70.6% | -64.1% | 654.9% | – |
| Gross Profit | $48,949 | $225,015 | $652,540 | $51,642 |
| % Margin | 69.5% | 94.1% | 97.9% | 58.5% |
| EBITDA | -$190,969 | $120,535 | $533,909 | -$53,479 |
| % Margin | -271.1% | 50.4% | 80.1% | -60.6% |
| Net Income | -$202,379 | $106,508 | $518,646 | -$81,030 |
| % Margin | -287.3% | 44.5% | 77.8% | -91.8% |
| EPS Diluted | -1.25 | 0.6 | 2.93 | -0.51 |
| % Growth | -308.3% | -79.5% | 674.5% | – |
| Operating Cash Flow | $107,804 | -$127,462 | -$185,502 | -$173,163 |
| Capital Expenditures | -$2,017 | -$247 | -$1,595 | -$2,252 |
| Free Cash Flow | $105,787 | -$127,709 | -$187,097 | -$175,415 |